Form 4: Tela Bio Executive Peter Murphy Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Peter Murphy, Chief Commercial Officer of TELA Bio, Inc., reports the withholding of shares to cover taxes upon vesting of restricted stock units.
Summary
- On March 31, 2024, Peter C. Murphy, Chief Commercial Officer of TELA Bio, Inc., had 163 shares of common stock withheld by the issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units.
- The price per share for the transaction was $5.67.
- Following the transaction, Murphy beneficially owns 48,129 shares of TELA Bio, Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding a tax-related stock transaction, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine tax withholding.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of the stock transaction (tax withholding). |
| 04/02/2024 | Date of signature by Attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.